Literature DB >> 28438465

Isaacs syndrome with CASPR2 antibody: A series of three cases.

Jie Song1, Sisi Jing1, Chao Quan1, Jun Lu1, Xiangyang Qiao1, Kai Qiao2, Jiahong Lu1, Jianying Xi3, Chongbo Zhao4.   

Abstract

Isaacs syndrome is a form of peripheral nerve hyperexcitability, characterized by spontaneous muscle twitching and stiffness. Some patients are reported to be positive for CASPR2 antibody that may be one of the pathogenic autoantibodies in Isaacs syndrome. We reported a series of three patients with Isaacs syndrome, including their clinical features, electrophysiologic findings, laboratory parameters and therapeutic responses. All the three patients were positive for CASPR2 antibodies examined on transfected human embryonic kidney 293 cells by indirect immunofluorescence method. One patient had invasive thymoma. Symptomatic treatment was not sufficient for them, while immunotherapies including corticosteroids, double filtration plasmapheresis and rituximab provided favorable outcomes. The titers of CASPR2 antibody decreased after immune modulating therapy in parallel to clinical improvements in two patients.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  CASPR2 antibody; Immunotherapy; Isaacs syndrome

Mesh:

Substances:

Year:  2017        PMID: 28438465     DOI: 10.1016/j.jocn.2017.02.063

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

1.  Issacs Syndrome in a Pediatric Patient and Voltage-Gated Potassium Channels Antibodies.

Authors:  Andreia Forno; Alexandra Rodrigues; Rui Vasconcellos; Paulo Rego Sousa
Journal:  Neurol Clin Pract       Date:  2021-08

Review 2.  Current Treatment Options for Peripheral Nerve Hyperexcitability Syndromes.

Authors:  Cheran Elangovan; Adeolu Morawo; Aiesha Ahmed
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.972

3.  Isaacs' syndrome as the initial presentation of malignant thymoma and associated with double-positive voltage-gated potassium channel complex antibodies, a case report.

Authors:  Kuan-Ching Li; Ming-Feng Liao; Yih-Ru Wu; Rong-Kuo Lyu
Journal:  BMC Neurol       Date:  2022-03-04       Impact factor: 2.474

4.  Isaac Syndrome with Intractable Neuropathic Pain Features: A Case Report.

Authors:  Mustafa Al-Chalabi; Nicholas R DelCimmuto; Pratyush Pavan Devarasetty; Jayasai Jeyarajan; Blair N Baumle; Noor Pirzada
Journal:  Case Rep Neurol       Date:  2022-03-29

5.  Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody.

Authors:  Ying Hou; Chao Zhang; Xiaolin Yu; Wenqing Wang; Dong Zhang; Yunfei Bai; Chuanzhu Yan; Lin Ma; Anning Li; Jian Ji; Lili Cao; Qinzhou Wang
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.